Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin‐A
- 28 May 2003
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 24 (11) , 1871-1878
- https://doi.org/10.1002/elps.200305430
Abstract
A pancreatic adenocarcinoma cell line (Paca44) was treated with trichostatin‐A (TSA), a potent inhibitor of histone deacetylases, in order to evaluate the effect of this drug on protein expression. Master maps of control and treated Paca44 cells were generated by analysis with the PDQuest software. The comparison between such maps showed up‐ and downregulation of 51 polypeptide chains, out of a total of 700 spots detected by a medium‐sensitivity stain, micellar Coomassie Brilliant Blue. Fingerprinting by matrix‐assisted laser desorption/ionization‐time of flight (MALDI‐TOF)‐mass spectrometry analysis enabled the identification of 22 of these spots. Among these proteins, of particular interest are the two downregulated proteins nucleophosmin and translationally controlled tumor protein, as well as the upregulated proteins programmed cell death protein 5 (also designated as TFAR19) and stathmin (oncoprotein 18). The modulation of these four proteins is consistent with our observation that TSA is able to inhibit cell growth of Paca44 by causing cell cycle arrest at the G2 phase and apoptotic cell death.Keywords
This publication has 27 references indexed in Scilit:
- Histone deacetylase inhibitors: from target to clinical trialsExpert Opinion on Investigational Drugs, 2002
- The role of nucleophosmin in centrosome duplicationOncogene, 2002
- Modern strategies for protein quantification in proteome analysis: Advantages and limitationsMass Spectrometry Reviews, 2002
- Nucleophosmin regulates the stability and transcriptional activity of p53Nature Cell Biology, 2002
- Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis?FEBS Letters, 2001
- Cellular distribution of translationally controlled tumor protein in rat and human testesProteomics, 2001
- Histone acetylation and cancerCurrent Opinion in Genetics & Development, 1999
- Modifying chromatin and concepts of cancerCurrent Opinion in Genetics & Development, 1999
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesPublished by Elsevier ,1988